Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
In our study, the mean changes in SMBG levels were not significantly different between the groups, except the SMBG level 1 hr after dinner
Novo Nordisks new oral GLP-1, Wegovy pill, is a once-daily pill offering comparable weight-loss results (an average of 13.6% of your body weight) to injectable Wegovy.^ ^Eligible patients lost an average of 13.6% of their body weight in a 64-week clinical trial evaluating 25 mg oral semaglutide compared to those on 2.4 mg injectable semaglutide who lost an average of 14.9% of their body weight in a 68-week clinical trial
Contact: Alex Cook Senior Public Relations Manager 612.777.4217 [email protected] SOURCE Prime Therapeutics LLC
Anim., 59, e14589, 2024
US$ 26.36
US$ 28.69
US$ 20.89
US$ 27.48
US$ 22.78
US$ 20.31
US$ 27.75
US$ 21.80
US$ 29.83
US$ 24.38
